BFW
ABBV icon

Brady Family Wealth’s AbbVie ABBV Stock Holding History

Brady Family Wealth’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.69M Sell
6,715
-7
-0.1% -$1.51K 0.49% 55
2026
Q1 		$1.46M Buy
6,722
+61
+0.9% +$13.5K 0.46% 54
2025
Q4 		$1.52M Buy
6,661
+129
+2% +$29.4K 0.47% 54
2025
Q3 		$1.51M Buy
6,532
+440
+7% +$89.6K 0.47% 50
2025
Q2 		$1.13M Buy
6,092
+132
+2% +$24.5K 0.35% 60
2025
Q1 		$1.25M Buy
5,960
+6
+0.1% +$1.17K 0.4% 60
2024
Q4 		$1.06M Sell
5,954
-57
-0.9% -$10.5K 0.32% 63
2024
Q3 		$1.19M Sell
6,011
-8
-0.1% -$1.49K 0.36% 61
2024
Q2 		$1.03M Hold
6,019
– – 0.33% 62
2024
Q1 		$1.1M Hold
6,019
– – 0.36% 62
2023
Q4 		$933K Sell
6,019
-821
-12% -$120K 0.32% 65
2023
Q3 		$1.02M Sell
6,840
-140
-2% -$20.6K 0.39% 59
2023
Q2 		$940K Hold
6,980
– – 0.35% 65
2023
Q1 		$1.11M Sell
6,980
-135
-2% -$20.6K 0.44% 57
2022
Q4 		$1.15M Buy
+7,115
New +$1.09M 0.47% 56

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Brady Family Wealth's ABBV Position: Q2 2026 in Review

Brady Family Wealth reduced its AbbVie (ABBV) stake by 0.1% in Q2 2026, selling an estimated $1.51K and leaving 6,715 shares worth $1.69M. The position accounts for 0.49% of the portfolio, ranked #55.

Brady Family Wealth first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,207 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Brady Family Wealth held 6,715 shares of AbbVie worth $1.69M as of Q2 2026.
  • Brady Family Wealth sold 7 AbbVie shares in Q2 2026, an estimated $1.51K.
  • AbbVie made up 0.49% of Brady Family Wealth's portfolio in Q2 2026, its #55 holding.
  • Brady Family Wealth first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,207 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Brady Family Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.